Genomenon
Accelerating NGS variant interpretation, this drug discovery software enables rapid exploration of genomic literature, offering insights into over 26 million variants. Researchers can efficiently prioritize variants linked to diseases and therapies, leveraging a robust database and expert curation to streamline analysis and enhance confidence in identifying disease-causing variants, ultimately advancing precision medicine.
Top Genomenon Alternatives
StackScan
Find and compile website lists based on the technology stacks they use, covering 50,000+ technologies across 105 million domains.
BIOiSIM
A pioneering virtual drug development engine, BIOiSIM® streamlines drug discovery by identifying compounds likely to succeed in treating specific diseases. Built on extensive data across multiple species, it enhances translational accuracy and minimizes R&D waste, enabling faster pathways to clinical trials and ultimately improving patient outcomes with innovative therapies.
ArgusLab
ArgusLab is a molecular modeling and drug design software designed for Windows, gaining popularity despite its age, with over 20,000 downloads. Freely licensed, it’s ideal for educators wishing to enhance their students' learning experience without redistribution concerns. Efforts are underway to expand its accessibility to iPad and cross-platform systems.
FCS Express
FCS Express™ seamlessly transforms raw flow cytometry data into clear, presentation-ready results with remarkable efficiency. Designed for researchers familiar with Microsoft Office™, it enhances user experience and reduces complexity. With real-time data linking and intuitive interfaces, it empowers clinical and academic labs to deliver accurate analyses effortlessly.
ChemDraw
ChemDraw® solutions have been empowering chemists since 1985, transforming complex ideas into polished publications. With ChemOffice+ Cloud, users can efficiently manage and present their research, leveraging tools that streamline the creation of reports and presentations. This suite enhances communication by facilitating the organization and reuse of chemical data and structures.
DNAnexus Apollo
DNAnexus Apollo™ revolutionizes precision drug discovery by integrating multimodal data, analytics, and collaboration tools in a secure cloud platform. It enables scientists to seamlessly combine omics and clinical data, deploy bioinformatics pipelines, and leverage AI/ML algorithms, fostering a collaborative environment that accelerates insights and enhances data-driven research.
Evidex
Evidex streamlines automated surveillance across diverse data sources, seamlessly integrating with a GVP IX compliant signal management platform. This innovative solution enhances safety data analysis by combining traditional and unstructured data, optimizing signaling algorithms, and enabling efficient validations. It empowers organizations to prioritize value-driven safety management while ensuring regulatory compliance.
Recursion
Leveraging proprietary biological, chemical, and real-world patient data, this advanced biotechnology company utilizes a supercomputer, BioHive-2, to scale up drug discovery. By producing over 1 trillion hiPSC-derived neuronal cells and employing CRISPR and advanced robotics, it decodes complex gene-compound relationships to revolutionize the pharmaceutical landscape.
Gritstone
Gritstone leverages its proprietary Gritstone EDGE™ platform to identify and analyze tumor-specific neoantigens through advanced machine learning. By integrating extensive data from diverse patient samples, it effectively pinpoints which mutations are transcribed and presented by HLA molecules, enhancing the development of targeted cancer immunotherapies.
Atomwise
Harnessing the power of AI, this platform revolutionizes drug discovery by integrating machine learning with vast chemical libraries. Its innovative engine employs convolutional neural networks to efficiently explore trillions of compounds, increasing the probability of identifying effective small-molecule medicines. The focus remains on tackling challenging targets to enhance drug developers' success rates.
Kaleido
Kaleido pioneers the exploration of the human microbiome, a complex ecosystem of over 30 trillion microbes linked to various health disorders. By developing innovative therapeutic solutions that harness this intricate microbial community, Kaleido aims to transform patient care, addressing conditions like cardiovascular disease and diabetes with precision and insight.
SCIEX
This drug discovery software seamlessly integrates with high-performance LC-MS/MS systems, enhancing data acquisition and analysis for precise molecular detection. With tailored workflow modules, users can optimize quantitative and qualitative assessments, leading to faster, more reliable results. Its user-friendly interface simplifies daily operations and training, maximizing laboratory efficiency.
Aurora Drug Discovery
Leveraging advanced quantum mechanics and thermodynamics, Aurora Drug Discovery utilizes an innovative continuous water model to calculate ligand binding affinities. By incorporating entropy and electrostatic contributions directly into its algorithms, Aurora generates precise binding free energy values, enhancing the prediction of inhibition constants and improving drug discovery outcomes significantly.
Phoenix PK/PD Platform
The Phoenix™ PK/PD Platform equips scientists with advanced tools for pharmacokinetic and pharmacodynamic modeling, facilitating robust analysis from preclinical to regulatory phases. With features like non-compartmental analysis, population modeling, and in vitro-in vivo correlation, it enhances decision-making, ensures regulatory compliance, and streamlines workflows across drug development stages.
SILCS
SILCS is a cutting-edge drug discovery software that employs Site Identification by Ligand Competitive Saturation to produce 3D FragMaps, revealing interaction patterns of functional groups with target molecules. This platform enhances ligand optimization through dynamic insights into binding pockets, facilitating efficient drug design and rapid exploration of favorable interactions.
Schrödinger
Transforming drug discovery and materials research, Schrödinger's advanced molecular modeling platform leverages physics-driven computational solutions for predictive modeling and data analytics. Employed across diverse industries, from pharmaceuticals to aerospace, it facilitates rapid exploration of chemical spaces, optimizing workflows and enhancing collaboration to tackle critical research challenges effectively.
Company Information
- Company: Genomenon, Inc
- Country: United States
Top Genomenon Features
- Rapid NGS variant interpretation
- Comprehensive genetics view
- Germline and somatic exploration
- 26 million variant articles
- Cancer Knowledgebase integration
- Tailored expert solutions
- Constantly updated genomic database
- Pre-classified variant catalog
- Genomic Intelligence Platform
- Optimized variant prioritization
- Mastermind publication access
- Filterable literature results
- Gene page integration
- Enhanced Evidence page navigation
- AI-driven patient assessments
- Complete genomic data access
- Precision medicine support
- Empirical evidence backing
- Pathogenic variant identification
- Efficient research workflows
